NCCN指南®洞察:前列腺癌,版本3.2024
Edward M Schaeffer1, Sandy Srinivas2, Nabil Adra3
11Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
Journal of the National Comprehensive Cancer Network : JNCCN
|April 16, 2024
概括
国家综合癌症网络 (NCCN) 更新了其2024年前列腺癌指南. 关键的变化集中在初始风险分层,非常低风险疾病管理和非转移性复发治疗策略上.
科学领域:
- 在瘤学瘤学.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 临床指南 临床指南
背景情况:
- 国家综合癌症网络 (NCCN) 为癌症护理提供基于证据的指导方针.
- 前列腺癌的管理需要准确的分期,风险评估和量身定制的治疗策略.
- 定期更新指南对于纳入前列腺癌诊断和治疗方面的进展至关重要.
研究的目的:
- 总结2024年NCCN前列腺癌指南的关键更新.
- 要突出初始风险分层和管理的变化,非常低风险的前列腺癌.
- 概述前列腺癌患者治疗非转移性复发的最新建议.
主要方法:
- 对2024年NCCN前列腺癌指南更新的小组讨论和决定的审查.
- 专注于具体领域:初始风险分层,非常低风险疾病管理和非转移性复发.
- 在前列腺癌护理中临床应用的综合建议.
主要成果:
- 2024年更新包括对诊断后初始风险分层的改进建议.
- 针对非常低风险前列腺癌的具体管理策略已经得到解决.
- 这些指南提供了对非转移性复发的治疗方法的最新方法.
结论:
- "NCCN指南见解"提供了关键的2024前列腺癌指南变化的简要概述.
- 这些更新旨在优化前列腺癌各个阶段患者的护理.
- 修订后的指导方针支持初步风险评估和治疗复发的知情决策.
更多相关视频
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13.1K
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.1K
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Standards of Care II
644
Nurses bear specific legal responsibilities under several federal statutes, including:
644
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Standards of Care I
677
Federal statutes profoundly impact nursing practice, providing critical guidelines to ensure patient care is equitable, accessible, and of the highest quality. The following laws address distinct aspects of healthcare provision and patient rights:
677
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
